P2.02-065 RanBP9 is a Novel Prognostic and Predictive Biomarker for NSCLC and Affects Cellular Response to Cisplatin and PARP Inhibitors

Autor:	K. M. D. La Perle, Claudia Foray, Eliana Rulli, Valerio Embrione, Vincenzo Coppola, Anna Tessari, Matteo Fassan, Kareesma Parbhoo, Meghan Pawlikowski, Massimo Broggini, Joseph M. Amann, Monica Ganzinelli, Dario Palmieri, Alessandra Fabbri, M.C. Garassino, David P. Carbone, Carlo M. Croce
Rok vydání:	2017
Předmět:	Pulmonary and Respiratory Medicine Oncology Cisplatin medicine.medical_specialty business.industry Poly ADP ribose polymerase Internal medicine Medicine business medicine.drug Predictive biomarker
Zdroj:	Journal of Thoracic Oncology. 12:S2123-S2124
ISSN:	1556-0864
DOI:	10.1016/j.jtho.2017.09.1243
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::de92eda4bd3907aae78affc27823a2a6 https://doi.org/10.1016/j.jtho.2017.09.1243 Zobrazit plný text záznamu